子宫颈神经内分泌癌中人乳头瘤病毒(HPV)归因的系统综述与Meta分析
该系统综述与Meta分析检索PubMed和Embase至2017年6月1日,纳入32项SCNC研究(403例)和9项LCNC研究(45例),直接检测癌组织HPV。SCNC中85%为HPV阳性,51%为单一HPV18阳性;LCNC中88%为HPV阳性,30%为单一HPV18阳性。作者结论认为多数SCNC和LCNC由HPV(主要是HPV18和HPV16)引起,现有预防性HPV疫苗将预防多数甚至全部此类肿瘤。
要点
- SCNC中85%(95%CI=71%-94%)为HPV阳性,51%(95%CI=39%-64%)为单一HPV18阳性。
- LCNC中88%(95%CI=72%-99%)为HPV阳性,30%(95%CI=4%-60%)为单一HPV18阳性。
- 作者结论认为多数SCNC和LCNC由HPV18和HPV16引起,现有预防性HPV疫苗可预防多数甚至全部此类肿瘤。
核心结论
- 多数SCNC和LCNC由HPV引起,主要是HPV18和HPV16。
- 作者认为现有预防性HPV疫苗将预防多数甚至全部SCNC和LCNC。
研究设计与样本
- 系统综述与Meta分析,检索PubMed和Embase至2017年6月1日,初检143篇文章。
- 纳入标准限定为直接检测癌组织HPV的方法以减少错误归因。
- 纳入32项SCNC研究共403例和9项LCNC研究共45例进行分析。
主要发现
- SCNC中85%(95%CI=71%-94%)为HPV阳性,78%(95%CI=64%-90%)为HPV16和/或HPV18阳性。
- SCNC中51%(95%CI=39%-64%)为单一HPV18阳性,10%(95%CI=4%-19%)为单一HPV16阳性。
- 5项SCNC研究(75例)亚组中,93%经免疫组化p16INK4a阳性,100%为HPV阳性。
- LCNC中88%(95%CI=72%-99%)为HPV阳性,86%(95%CI=70%-98%)为HPV16或HPV18阳性。
- LCNC中30%(95%CI=4%-60%)为单一HPV18阳性,29%(95%CI=2%-64%)为单一HPV16阳性。
关键数值与推荐
- SCNC HPV阳性率85%(95%CI=71%-94%),HPV16和/或HPV18阳性率78%(95%CI=64%-90%)。
- SCNC单一HPV18阳性率51%(95%CI=39%-64%),单一HPV16阳性率10%(95%CI=4%-19%)。
- LCNC HPV阳性率88%(95%CI=72%-99%),HPV16或HPV18阳性率86%(95%CI=70%-98%)。
- LCNC单一HPV18阳性率30%(95%CI=4%-60%),单一HPV16阳性率29%(95%CI=2%-64%)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There remains uncertainty about the role of human papillomavirus (HPV) infection in causing small-cell neuroendocrine carcinoma (SCNC) and large-cell neuroendocrine carcinoma (LCNC) of the cervix. To clarify the role of HPV in the development of SCNC and LCNC, we conducted a systematic review and meta-analyses. METHODS: PubMed and Embase were searched to initially identify 143 articles published on or before June 1, 2017. Studies were limited to methods that tested for HPV in the cancer tissue directly to minimize misattribution. Thirty-two studies with 403 SCNC and 9 studies of 45 LCNC were included in the analysis. RESULTS: For SCNC, 85% (95% confidence interval [95%CI]=71%-94%) were HPV positive, 78% (95%CI=64%-90%) were HPV16 and/or HPV18 positive, 51% (95%CI=39%-64%) were singly HPV18 positive, and 10% (95%CI=4%-19%) were singly HPV16 positive. In a subset of 5 SCNC studies (75 cases), 93% were positive for p16INK4a by immunohistochemistry and 100% were HPV positive. For LCNC, 88% (95%CI=72%-99%) were HPV positive, 86% (95%CI=70%-98%) were positive for HPV16 or HPV18, 30% were singly HPV18 positive (95%CI=4%-60%), and 29% (95%CI=2%-64%) were singly HPV16 positive. CONCLUSIONS: In conclusion, most SCNC and LCNC are caused by HPV, primarily HPV18 and HPV16. Therefore, most if not all SCNC and LCNC will be prevented by currently available prophylactic HPV vaccines.
引用
- Castle PE, Pierz A, Stoler MH, et al. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecol Oncol. 2017. PMID: 29248196. doi:10.1016/j.ygyno.2017.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。